Ubs Group Ag Nuvasive Inc Transaction History

Ubs Group Ag

  • $397 Billion
  • Q1 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$36.71 - $44.15 $8.25 Million - $9.92 Million
-224,758 Reduced 97.93%
4,740 $197,000
Q1 2023

May 12, 2023
SELL
$36.81 - $48.12 $8.49 Million - $11.1 Million
-230,753 Reduced 50.14%
229,498 $9.48 Million
Q4 2022

Feb 08, 2023
BUY
$35.68 - $44.71 $8.51 Million - $10.7 Million
238,433 Added 107.49%
460,251 $19 Million
Q3 2022

Nov 10, 2022
SELL
$42.51 - $54.02 $22.7 Million - $28.8 Million
-532,828 Reduced 70.61%
221,818 $9.72 Million
Q2 2022

Aug 10, 2022
SELL
$46.84 - $59.75 $15 Million - $19.1 Million
-320,456 Reduced 29.81%
754,646 $37.1 Million
Q1 2022

May 16, 2022
BUY
$48.09 - $57.79 $21.6 Million - $26 Million
449,937 Added 71.97%
1,075,102 $61 Million
Q4 2021

Feb 14, 2022
BUY
$47.19 - $62.68 $8.01 Million - $10.6 Million
169,828 Added 37.3%
625,165 $32.8 Million
Q3 2021

Nov 15, 2021
BUY
$56.91 - $67.81 $25 Million - $29.8 Million
439,043 Added 2694.51%
455,337 $27.3 Million
Q2 2021

Aug 13, 2021
SELL
$64.02 - $71.72 $120,741 - $135,263
-1,886 Reduced 10.37%
16,294 $1.11 Million
Q1 2021

May 12, 2021
SELL
$53.26 - $68.08 $1.77 Million - $2.27 Million
-33,315 Reduced 64.7%
18,180 $1.19 Million
Q4 2020

Feb 11, 2021
BUY
$43.41 - $56.51 $673,896 - $877,261
15,524 Added 43.16%
51,495 $2.9 Million
Q3 2020

Nov 12, 2020
BUY
$47.43 - $60.75 $733,078 - $938,952
15,456 Added 75.34%
35,971 $1.75 Million
Q2 2020

Jul 31, 2020
SELL
$43.51 - $66.59 $761,163 - $1.16 Million
-17,494 Reduced 46.03%
20,515 $1.14 Million
Q1 2020

May 01, 2020
SELL
$32.82 - $81.13 $2.62 Million - $6.48 Million
-79,901 Reduced 67.76%
38,009 $1.93 Million
Q4 2019

Feb 14, 2020
BUY
$60.96 - $77.7 $2.87 Million - $3.65 Million
47,024 Added 66.34%
117,910 $9.12 Million
Q3 2019

Nov 14, 2019
BUY
$55.78 - $68.08 $1.91 Million - $2.33 Million
34,207 Added 93.26%
70,886 $4.49 Million
Q2 2019

Aug 14, 2019
BUY
$53.69 - $65.47 $1.09 Million - $1.33 Million
20,276 Added 123.61%
36,679 $2.15 Million
Q1 2019

May 14, 2019
SELL
$44.53 - $58.9 $1.23 Million - $1.63 Million
-27,681 Reduced 62.79%
16,403 $931,000
Q4 2018

Feb 14, 2019
BUY
$47.64 - $71.26 $208,186 - $311,406
4,370 Added 11.0%
44,084 $2.19 Million
Q3 2018

Nov 14, 2018
SELL
$52.03 - $71.41 $1.04 Million - $1.43 Million
-20,068 Reduced 33.57%
39,714 $2.82 Million
Q2 2018

Aug 14, 2018
SELL
$48.15 - $56.68 $1.01 Million - $1.19 Million
-20,912 Reduced 25.92%
59,782 $3.12 Million
Q1 2018

May 15, 2018
SELL
$46.03 - $61.28 $267,250 - $355,791
-5,806 Reduced 6.71%
80,694 $4.21 Million
Q4 2017

Feb 14, 2018
SELL
$50.58 - $60.79 $17,096 - $20,547
-338 Reduced 0.39%
86,500 $5.06 Million
Q3 2017

Nov 14, 2017
BUY
$53.54 - $68.0 $723,700 - $919,156
13,517 Added 18.44%
86,838 $4.82 Million
Q2 2017

Aug 14, 2017
SELL
N/A
-24,258 Reduced 24.86%
73,321 $5.64 Million
Q1 2017

Nov 14, 2017
BUY
N/A
97,579
97,579 $7.29 Million

Others Institutions Holding NUVA

# of Institutions
9
Shares Held
116K
Call Options Held
0
Put Options Held
0
View Full List

About NUVASIVE INC

NUVA Quotes by TradingView
  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email